GENEVANT
LIVE

Serial Number

79237909

Owner

GENEVANT SCIENCES GMBH

Attorney

Allison Strickland Ricketts

Filing Date

Apr 23, 2018

Add to watchlist:

No watchlists yet
View on USPTO

GENEVANT Trademark

Serial Number: 79237909 • Registration: 5946662

GENEVANT is a trademark filed by GENEVANT SCIENCES GMBH on April 23, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENEVANT SCIENCES GMBH (4 trademarks)

VIADUKTSTRASSE 8
BASEL 4051 , CH

Entity Type: 27

Trademark Details

Filing Date

April 23, 2018

Registration Date

December 31, 2019

Published for Opposition

October 15, 2019

Goods & Services

Pharmaceutical preparations for human use to treat genetic diseases and disorders and diseases and disorders associated with insufficient or faulty protein production or overproduction; biological preparations for medical or therapeutic use to treat genetic diseases and disorders and diseases and disorders associated with insufficient or faulty protein production or overproduction

Provision of health information and medical information; provision of information concerning the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, disorders and pathologies

Scientific and technological services as well as research and design services relating thereto, namely, scientific research and development and product research and development; biomedical and pharmaceutical research services; research in the field of therapeutic biological and pharmaceutical preparations; pharmaceutical research and development; providing information relating to scientific research in the field of pharmaceutical and biomedicine

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 31, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 11, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 8, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 16, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 16, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 31, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 12, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 25, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 25, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2019 NONP
ASSIGNED TO LIE
Sep 12, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 9, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 9, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 9, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 9, 2019 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 9, 2019 GNFN
FINAL REFUSAL E-MAILED
Mar 9, 2019 GNFR
FINAL REFUSAL WRITTEN
Mar 9, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2019 TROA
ATTORNEY REVIEW COMPLETED
Dec 7, 2018 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Dec 7, 2018 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 23, 2018 CRCV
REFUSAL PROCESSED BY IB
Oct 19, 2018 RFNP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 11, 2018 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 4, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 4, 2018 RFRR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 30, 2018 TCCA
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 18, 2018 RFCR
NON-FINAL ACTION WRITTEN
Aug 17, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 14, 2018 MAFR
ASSIGNED TO EXAMINER
Aug 13, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 7, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 2, 2018 REPR